EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

Recruiting now

Conditions studied: Myocarditis, ANCA Associated Vasculitis, Pericarditis, Systemic Sclerosis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis, Spondylarthritis, Behcet Disease, Takayasu Arteritis, Sarcoidosis, Still Disease, Tako Tsubo Cardiomyopathy

In brief

Inflammatory Cardiovascular Diseases and Autoimmune Rheumatic Diseases (ICARDs) encompass cardiovascular involvement in connective tissue diseases, vasculitis, and primary inflammatory cardiac processes affecting all layers of the heart. ICARDs are associated with increased cardiovascular morbidity and mortality, independently of traditional risk factors, via multiple pathophysiological mechanisms. Diagnosis and prognosis are challenged by the heterogeneity of clinical presentations. Multimodality cardiovascular imaging - including cardiovascular magnetic resonance (CMR), transthoracic echocardiography, and positron emission tomography (PET) - plays a central role in detecting and characterizing inflammatory involvement, and may offer prognostic insights. Given the limited data on the diagnostic and prognostic utility of these imaging modalities in ICARDs, the EACVI-INFLAME study aims to assess the prevalence of confirmed cardiovascular involvement in patients with suspected or established ICARDs undergoing CMR and/or cardiac PET in a multicentric international cohort.

Key facts

Study ID
NCT07077304
Run by
Assistance Publique - Hôpitaux de Paris
People needed
5000
Starts
2025-11-19
Expected to finish
2028-10-30
Last updated by the study team
2026-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.